Mehta Rajat (CIK 2081681) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-09). Recent activity: Buy BIO BIO.B (456 shares), Sell BIO BIO.B (233 shares), Buy BIO BIO.B (1,370 shares), Sell BIO BIO.B (504 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-09 | BIO-RAD LABORATORIES, INC. (BIO BIO.B) | EVP, GBL Commercial Operations | Buy | 456 | $0 |
| 2026-09-09 | BIO-RAD LABORATORIES, INC. (BIO BIO.B) | EVP, GBL Commercial Operations | Sell | 233 | $89,964 |
| 2026-09-09 | BIO-RAD LABORATORIES, INC. (BIO BIO.B) | EVP, GBL Commercial Operations | Buy | 1,370 | $0 |
| 2026-09-09 | BIO-RAD LABORATORIES, INC. (BIO BIO.B) | EVP, GBL Commercial Operations | Sell | 504 | $194,599 |
来源：SEC Form 4 申报文件 · 截至 2026-09-09